VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |